Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.37 |
| ▸ | INSR | P06213 | 2/20 | 0.35 |
| ▸ | APP | P05067 | 5/20 | 0.33 |
| ▸ | SNCA | P37840 | 3/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | CASP1 | P29466 | 2/20 | 0.32 |
| ▸ | CASP7 | P55210 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL28295077 | 0.99 | PDGFRB (0.41) | PDGFRBALDH1A1TSHRHTR7INSR | |
| Hydrochloric Acid SCHEMBL28166077 | 0.99 | PDGFRB (0.41) | PDGFRBALDH1A1TSHRHTR7INSR | |
| SCHEMBL28924615 | 0.77 | PDGFRB (0.36) | PDGFRBALDH1A1TSHRHTR7MEN1 | |
| SCHEMBL30160329 | 0.77 | PDGFRB (0.36) | PDGFRBALDH1A1TSHRHTR7MEN1 | |
| SCHEMBL21970993 | 0.72 | PDGFRB (0.43) | PDGFRBALDH1A1TSHRHTR7SNCA | |
| SCHEMBL30542467 | 0.70 | NPSR1 (0.34) | KMT2A | |
| SCHEMBL11515562 | 0.70 | NPSR1 (0.34) | KMT2A | |
| SCHEMBL11516459 | 0.69 | SNCA (0.44) | PDGFRBALDH1A1TSHRHTR7APP | |
| SCHEMBL9307101 | 0.68 | AADAT (0.34) | SMN1; SMN2TDP1TP53 | |
| SCHEMBL4625857 | 0.68 | ALOX5 (0.41) | ALDH1A1HTR7ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109266784-B | Closed DNA fluorescent biosensor and application thereof in detection of influenza A H1N1 virus | 广东海洋大学 | 2022-04-08 | — | — | CN | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| CN-115517262-B | Application of thioflavin T in resisting plant virus | 中国科学院武汉植物园 | 2023-11-07 | — | — | CN | disclosed |
| CN-115517262-B | Application of thioflavin T in resisting plant virus | 中国科学院武汉植物园 | 2023-11-07 | — | — | CN | disclosed |
| CN-109266783-B | Molecular beacon-G quadruplex optical sensor and application thereof in detection of SV40 virus | 广东海洋大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-109266784-B | Closed DNA fluorescent biosensor and application thereof in detection of influenza A H1N1 virus | 广东海洋大学 | 2022-04-08 | — | — | CN | disclosed |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | VERVA PHARMACEUTICALS PTY LTD (AU) | 2005-12-22 | — | — | US | disclosed |
| CN-1173954-C | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | 3 | 2004-11-03 | — | — | CN | disclosed |
| CN-1312252-A | Intermediate of chemical compound generating chemical illumination when reacts with phosphatase | RUMIGEN CO (US) | 2001-09-12 | — | — | CN | disclosed |
| CN-1180349-A | Compounds, compositions and methods for generating chemiluminescence by reaction with phosphatases | LUMIGEN INC (US) | 1998-04-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | FGF1, FABP4, FGF2 | PDGFRB 467/4885ALDH1A1 1103/4885TSHR 2056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.